OTC Pharmaceuticals: Global Industry Guide

Table of Contents

List of Figures

CHAPTER 1 INTRODUCTION

• 1.1 What is this report about?
• 1.2 Who is the target reader?
• 1.3 How to use this report
• 1.4 Definitions

CHAPTER 2 Global OTC Pharmaceuticals

• 2.1 Market Overview
  • Research Highlights
  • Market Analysis
• 2.2 Market Value
• 2.3 Market Segmentation I
• 2.4 Market Segmentation II
• 2.5 Market Share
• 2.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 2.7 Leading Companies
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Novartis AG
• 2.8 Distribution
• 2.9 Market Forecasts
  • Market Value Forecast

CHAPTER 3 OTC Pharmaceuticals in Asia-Pacific

• 3.1 Market Overview
  • Research Highlights
  • Market Analysis
• 3.2 Market Value
• 3.3 Market Segmentation I
• 3.4 Market Segmentation II
• 3.5 Market Share
• 3.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 3.7 Leading Companies
  • Nin Jiom
  • Pfizer Inc
  • Novartis AG
• 3.8 Distribution
• 3.9 Market Forecasts
  • Market Value Forecast

CHAPTER 4 OTC Pharmaceuticals in Europe

• 4.1 Market Overview
  • Research Highlights
  • Market Analysis
• 4.2 Market Value
• 4.3 Market Segmentation I
• 4.4 Market Segmentation II
• 4.5 Market Share
• 4.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 4.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • GlaxoSmithKline Plc
• 4.8 Distribution
• 4.9 Market Forecasts
  • Market Value Forecast
• 4.10 Macroeconomic Indicators

CHAPTER 5 OTC Pharmaceuticals in Belgium

• 5.1 Market Overview
  • Research Highlights
  • Market Analysis
• 5.2 Market Value
• 5.3 Market Segmentation I
• 5.4 Market Segmentation II
• 5.5 Market Share
• 5.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 5.7 Leading Companies
  • Pfizer Inc
  • Novartis AG
  • Omega Pharma NV
• 5.8 Distribution
• 5.9 Market Forecasts
  • Market Value Forecast
• 5.10 Macroeconomic Indicators

CHAPTER 6 OTC Pharmaceuticals in Canada

• 6.1 Market Overview
  • Research Highlights
  • Market Analysis
• 6.2 Market Value
• 6.3 Market Segmentation I
• 6.4 Market Segmentation II
• 6.5 Market Share
• 6.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 6.7 Leading Companies
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Jamieson Laboratories
• 6.8 Distribution
• 6.9 Market Forecasts
  • Market Value Forecast
• 6.10 Macroeconomic Indicators

CHAPTER 7 OTC Pharmaceuticals in China

• 7.1 Market Overview
  • Research Highlights
  • Market Analysis
• 7.2 Market Value
• 7.3 Market Segmentation I
• 7.4 Market Segmentation II
• 7.5 Market Share
• 7.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 7.7 Leading Companies
  • Johnson & Johnson
• 7.8 Distribution
• 7.9 Market Forecasts
  • Market Value Forecast
• 7.10 Macroeconomic Indicators

CHAPTER 8 OTC Pharmaceuticals in France

• 8.1 Market Overview
  • Research Highlights
  • Market Analysis
• 8.2 Market Value
• 8.3 Market Segmentation I
• 8.4 Market Segmentation II
• 8.5 Market Share
• 8.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 8.7 Leading Companies
  • Procter & Gamble Company, The
  • Sanofi-Aventis
  • Pfizer Inc
• 8.8 Distribution
• 8.9 Market Forecasts
  • Market Value Forecast
• 8.10 Macroeconomic Indicators

CHAPTER 9 OTC Pharmaceuticals in Germany

• 9.1 Market Overview
  • Research Highlights
  • Market Analysis
• 9.2 Market Value
• 9.3 Market Segmentation I
• 9.4 Market Segmentation II
• 9.5 Market Share
• 9.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 9.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • GlaxoSmithKline Plc
• 9.8 Distribution
• 9.9 Market Forecasts
  • Market Value Forecast
• 9.10 Macroeconomic Indicators

CHAPTER 10 OTC Pharmaceuticals in Italy

• 10.1 Market Overview
  • Research Highlights
  • Market Analysis
• 10.2 Market Value
• 10.3 Market Segmentation I
• 10.4 Market Segmentation II
• 10.5 Market Share
• 10.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 10.7 Leading Companies
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • GlaxoSmithKline Plc
• 10.8 Distribution
• 10.9 Market Forecasts
  • Market Value Forecast
• 10.10 Macroeconomic Indicators

CHAPTER 11 OTC Pharmaceuticals in Japan

• 11.1 Market Overview
  • Research Highlights
  • Market Analysis
• 11.2 Market Value
• 11.3 Market Segmentation I
• 11.4 Market Segmentation II
• 11.5 Market Share
• 11.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 11.7 Leading Companies
  • Pfizer Inc
  • Novartis AG
  • Wyeth
• 11.8 Distribution
• 11.9 Market Forecasts
  • Market Value Forecast
• 11.10 Macroeconomic Indicators

CHAPTER 12 OTC Pharmaceuticals in the Netherlands

• 12.1 Market Overview
  • Research Highlights
  • Market Analysis
• 12.2 Market Value
• 12.3 Market Segmentation I
• 12.4 Market Segmentation II
• 12.5 Market Share
• 12.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 12.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • Procter & Gamble Company, The
• 12.8 Distribution
• 12.9 Market Forecasts